ReviewWorld journal of microbiology & biotechnology2026
Recent advances in chitosan-based nanomaterials for enhanced antimicrobial activity.
Review in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Marine-Derived Polysaccharide Nanofibers for Wound Healing: Mechanistic Rationale, Biofabrication Strategies, and Translational Barriers.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chitosan as a natural biopolymer derived from chitin has recently attracted significant attention in the field of medical sciences and antimicrobial materials. Chitosan has interesting properties including intrinsic antimicrobial properties, biocompatibility and biodegradability. Recent progress in nanotechnology has led to the development of chitosan-based nanomaterials with significant enhancement of antimicrobial activity including reduction of minimum inhibitory concentrations (MICs) and improvement of biofilm inhibition, for various biomedical applications. This mini-review explores the different antimicrobial mechanisms of chitosan and its derivative and try to highlight recent progress in the design, synthesis and application of chitosan-based nanomaterials against microbial infections. Furthermore, it focuses on different formulation types including nanoparticles, nanofibers and hydrogels for combating microbial infections. Additionally, current challenges and future directions for clinical translation of these nanomaterials are discussed.
Indexed as
Identifiers
42228203What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.